Larimar Therapeutics Inc (LRMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LRMR | AKBA | AMLX | ||
| Company | Larimar Therapeutics Inc | Akebia Therapeutics | Amylyx Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.16 | 1.8400 | 5.33 | ||
| High | 6.34 | 1.8995 | 5.40 | ||
| Low | 6.04 | 1.8050 | 5.15 | ||
| Last | 6.16 | 1.8800 | 5.27 | ||
| Change | +0.03 | +0.0600 | +0.08 | ||
| % Change | +0.49% | +3.30% | +1.54% | ||
| Volume | 402,000 | 2,012,300 | 837,800 | ||
| 20-Day Average Volume | 759,645 | 2,432,165 | 1,628,540 | ||
| Previous Close | 6.13 | 1.8200 | 5.19 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 7.64 | 1.8262 | 5.63 | ||
| 20-Day Raw Stochastic | 12.57% | 67.82% | 25.92% | ||
| 20-Day Relative Strength | 40.34% | 61.39% | 54.89% | ||
| Weighted Alpha | -13.84 | +40.74 | +119.26 | ||
| Today's Opinion | 88% Sell | 100% Buy | 64% Buy | ||
| Previous Opinion | 88% Sell | 100% Buy | 64% Buy | ||
| Last Month's Opinion | Hold | 56% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.92% since 11/15/24 | +5.03% since 11/15/24 | +10.71% since 11/15/24 | ||
| Low | 5.68 on 11/21/24 | 1.7500 on 11/21/24 | 4.98 on 11/21/24 | ||
| High | 6.62 on 11/18/24 | 1.8995 on 11/22/24 | 5.88 on 11/18/24 | ||
| 1-Month | |||||
| %Chg | -18.19% since 10/22/24 | +14.63% since 10/22/24 | +16.34% since 10/22/24 | ||
| Low | 5.68 on 11/21/24 | 1.5400 on 10/23/24 | 4.57 on 11/15/24 | ||
| High | 9.50 on 11/11/24 | 2.0200 on 11/11/24 | 7.27 on 11/08/24 | ||
| 3-Month | |||||
| %Chg | -20.10% since 08/22/24 | +27.89% since 08/22/24 | +137.39% since 08/22/24 | ||
| Low | 5.68 on 11/21/24 | 1.2400 on 10/01/24 | 2.05 on 08/28/24 | ||
| High | 9.50 on 11/11/24 | 2.0200 on 11/11/24 | 7.27 on 11/08/24 | ||
| 6-Month | |||||
| %Chg | -22.03% since 05/22/24 | +70.91% since 05/22/24 | +187.98% since 05/22/24 | ||
| Low | 5.68 on 11/21/24 | 0.8000 on 06/26/24 | 1.58 on 06/17/24 | ||
| High | 11.20 on 07/16/24 | 2.0200 on 11/11/24 | 7.27 on 11/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 393,051 | 410,180 | 361,248 | ||
| Shares Outstanding, K | 63,807 | 218,181 | 68,548 | ||
| Annual Sales | 0 | 194,620,000 | 380,790,000 | ||
| Annual Net Income | -36,950,000 | -51,930,000 | 49,270,000 | ||
| Last Quarter Sales | 0 | 37,430,000 | 420,000 | ||
| Last Quarter Net Income | -15,500,000 | -20,040,000 | -72,700,000 | ||
| 60-Month Beta | 0.95 | 0.74 | -0.70 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 10/30/24 | -0.10 on 11/07/24 | -0.53 on 11/07/24 | ||
| Latest Earnings Date | 11/12/24 | 11/07/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 03/28/18 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||